N/A
N=57
Ending Self Stigma for PTSD
Post Traumatic Stress Disorder
Bottom Line
View on ClinicalTrials.gov: NCT02734212 ↗Enrolled (actual)
57
Serious AEs
0.0%
Results posted
Jul 2017
Primary outcome: Primary: Internalized Stigma of Mental Illness Inventory (Internalized Stigma) — 2.5; 2.6; 2.1; 2.5 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Ending Self Stigma for PTSD (Behavioral); Enhanced Treatment as Usual (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- May 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Internalized Stigma of Mental Illness Inventory (Internalized Stigma) |
2.5; 2.6; 2.1; 2.5 | — |
| SECONDARY General Self-Efficacy |
54.7; 55.4; 57.6; 53.1 | — |
| SECONDARY Social Self-Efficacy |
16.1; 15.6; 18.2; 15.7 | — |
Summary
Veterans with PTSD report that stigma and fear of stigma have a chilling effect on their participation in mental health treatment. Despite the widely-documented effects of stigma on the recovery of individuals with mental illnesses and research demonstrating harmful consequences of internalized stigma, including decreased hope, self-esteem, personal motivation, and persistence regarding illness management, no interventions are currently available to assist Veterans with PTSD in combating the impact of internalized stigma. The goal of this research is to develop and pilot-test an intervention to provide Veterans with PTSD the skills to cope effectively with stigma and to mitigate the internalization of stigmatizing beliefs and stereotypes. To accomplish this purpose, Ending Self Stigma (ESS), an intervention composed of evidence-based methods for combating internalized stigma for serious mental illness, will be modified and tested to address issues particular to PTSD.
Eligibility Criteria
Inclusion Criteria
- a diagnosis of PTSD
- age between 18 and 70
- participation in mental health services at the VAMHCS
- sufficient clinical stability to participate
Exclusion Criteria
- a diagnosis of serious mental illness
- schizophrenia/schizoaffective disorder
- bipolar disorder
- major depression with psychotic features
- participation in the Phase I qualitative study
Data sourced from ClinicalTrials.gov (NCT02734212). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.